Evidence map›Paper›PMID 36406186›Full record

ArticleHealth and technology2022

Machine learning for optimizing daily COVID-19 vaccine dissemination to combat the pandemic.

David Opeoluwa Oyewola, Emmanuel Gbenga Dada, Sanjay Misra

Abstract read
In one paragraph

Article in Health and technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David Opeoluwa OyewolaDepartment of Mathematics and Computer Science, Federal University Kashere, Gombe, Nigeria.
Emmanuel Gbenga DadaDepartment of Mathematical Sciences, University of Maiduguri, Maiduguri, Nigeria.
Sanjay MisraDepartment of Computer Science and Communication, Østfold University College, Halden, Norway.ORCID 0000-0002-3556-9331

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Vaccines are the most important instrument for bringing the pandemic to a close and saving lives and helping to reduce the risks of infection. It is important that everyone has equal access to immunizations that are both safe and effective. There is no one who is safe until everyone gets vaccinated. COVID-19 vaccinations are a game-changer in the fight against diseases. In addition to examining attitudes toward these vaccines in Africa, Asia, Oceania, Europe, North America, and South America, the purpose of this paper is to predict the acceptability of COVID-19 vaccines and study their predictors. Materials and methods: Kaggle datasets are used to estimate the prediction outcomes of the daily COVID-19 vaccination to prevent a pandemic. The Kaggle data sets are classified into training and testing datasets. The training dataset is comprised of COVID-19 daily data from the 13th of December 2020 to the 13th of June 2021, while the testing dataset is comprised of COVID-19 daily data from the 14th of June 2021 to the 14th of October 2021. For the prediction of daily COVID-19 vaccination, four well-known machine learning algorithms were described and used in this study: CUBIST, Gaussian Process (GAUSS), Elastic Net (ENET), Spikes, and Slab (SPIKES). Results: Among the models considered in this paper, CUBIST has the best prediction accuracy in terms of Mean Absolute Scaled Error (MASE) of 9.7368 for Asia, 2.8901 for America, 13.2169 for Oceania, and 3.9510 for South America respectively. Conclusion: This research shows that machine learning can be of great benefit for optimizing daily immunization of citizens across the globe. And if used properly, it can help decision makers and health administrators to comprehend immunization rates and create strategies to enhance them.

Indexed as

COVID-19Elastic net (ENET)Gaussian process (GAUSS)Machine learningSpikes and slab (SPIKES)Vaccination

Identifiers

PMID36406186
PMCPMC9646469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.